Related references
Note: Only part of the references are listed.Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma
Kimberley Jones et al.
CLINICAL CANCER RESEARCH (2014)
microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics
Kishore B. Challagundla et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2014)
MicroRNA and Protein Profiling of Brain Metastasis Competent Cell-Derived Exosomes
Laura Camacho et al.
PLOS ONE (2013)
Circulating microRNA Profiling Identifies a Subset of Metastatic Prostate Cancer Patients with Evidence of Cancer-Associated Hypoxia
Heather H. Cheng et al.
PLOS ONE (2013)
Comparisons of microRNA Patterns in Plasma before and after Tumor Removal Reveal New Biomarkers of Lung Squamous Cell Carcinoma
Vasily N. Aushev et al.
PLOS ONE (2013)
Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
Casina W. S. Kan et al.
BMC CANCER (2012)
Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma
C. I. Jones et al.
BRITISH JOURNAL OF CANCER (2012)
Recent advances in miRNA-based diagnostic applications
Lorenzo F Sempere
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2012)
Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer
Manuel Valladares-Ayerbes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
Xiwei Wu et al.
PLOS ONE (2012)
The miRNA-drug resistance connection: a new era of personalized medicine using noncoding RNA begins
Prasun J. Mishra
PHARMACOGENOMICS (2012)
MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response
Muller Fabbri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
mRNA and microRNA Expression Profiles in Circulating Tumor Cells and Primary Tumors of Metastatic Breast Cancer Patients
Anieta M. Sieuwerts et al.
CLINICAL CANCER RESEARCH (2011)
Prognostic Significance of miR-215 in Colon Cancer
Mihriban Karaayvaz et al.
CLINICAL COLORECTAL CANCER (2011)
Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells
Bo Song et al.
MOLECULAR CANCER (2010)
Let-7 MicroRNA Family Is Selectively Secreted into the Extracellular Environment via Exosomes in a Metastatic Gastric Cancer Cell Line
Keiichi Ohshima et al.
PLOS ONE (2010)
MiR-24 Tumor Suppressor Activity Is Regulated Independent of p53 and through a Target Site Polymorphism
Prasun J. Mishra et al.
PLOS ONE (2009)
MicroRNA polymorphisms: a giant leap towards personalized medicine
Prasun J. Mishra
PERSONALIZED MEDICINE (2009)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance
Prasun J. Mishra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Share Paper
